Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

Trial Profile

Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Feb 2019

At a glance

  • Drugs Nitric oxide (Primary) ; Oxygen
  • Indications Bronchiolitis
  • Focus Registrational; Therapeutic Use
  • Acronyms NO-BRO
  • Sponsors AIT
  • Most Recent Events

    • 19 Sep 2018 According to an AIT Therapeutics Inc. media release, data from this trial were pesented at ERS and European Society of Clinical Microbiology and Infectious Diseases/American Society
    • 04 Sep 2018 According to an AIT Therapeutics Inc. media release, data from this trial at ERS and European Society of Clinical Microbiology and Infectious Diseases/American Society
    • 13 Jun 2018 Based on AIT Therapeutics media release, status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top